Ghani Chemical Industries Limited (GCIL): 3QFY25 Corporate Briefing Takeaways - By Taurus Research
May 9 2025
Taurus Securities
- Ghani Chemical Industries Limited (GCIL) is a leading manufacturer of medical and industrial gases in Pakistan. It operates state-of-the-art facilities across Phool Nagar (Punjab), Port Qasim (Sindh), and Hattar Special Economic Zone (KPK). The Company recently underwent a significant restructuring involving the demerger of its Calcium Carbide project and a share swap with Ghani Chemworld Limited and Ghani Products Limited.
- GCIL reported net sales of PKR 1.67Bn in 3QFY25, reflecting a 41% increase from PKR 1.18Bn in 3QFY24. Gross profit rose significantly to PKR 1.01Bn from PKR 305Mn, boosting the gross margin to 60.8% from 25.8% year-over-year. Net profit increased by 145% to PKR 514n compared to PKR 210Mn last year, with earnings per share (EPS) improving to PKR 1.03 from PKR 0.42.
- GCIL commenced operations of its 5th Air Separation Unit (ASU) at Hattar SEZ, with a 275 TPD capacity, making it the largest such facility in Pakistan. This addition positions GCIL as the dominant player in the industrial gases market. Management expects this to substantially increase both top-line and bottom-line going forward.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low